|
|
|||||||||||
The British Journal of Psychiatry 133: 82-82 (1978)
© 1978 The Royal College of Psychiatrists
AC Gibson
Twenty-five schizophrenic patients with tardive dyskinesia was given 600 mgs sodium valproate daily with their neuroleptic medication. After one month there was no change in their signs, as judged by a panel of nine viewing films of them taken before and at the end of this treatment.
This article has been cited by other articles:
![]() |
S. Korsgaard, D. E. Casey, J. Gerlach, O. Hetmar, B. Kaldan, and L. B. Mikkelsen The Effect of Tetrahydroisoxazolopyridinol (THIP) in Tardive Dyskinesia: A New {beta}-Aminobutyric Acid Agonist Arch Gen Psychiatry, September 1, 1982; 39(9): 1017 - 1021. [Abstract] [PDF] |
||||
![]() |
D. V. Jeste and R. Jed Wyatt Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience Arch Gen Psychiatry, July 1, 1982; 39(7): 803 - 816. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |